BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31668494)

  • 1. Desirable BUGS in models of infectious diseases.
    Auzenbergs M; Correia-Gomes C; Economou T; Lowe R; O'Reilly KM
    Epidemics; 2019 Dec; 29():100361. PubMed ID: 31668494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAGS model specification for spatiotemporal epidemiological modelling.
    Lope DJ; Demirhan H
    Spat Spatiotemporal Epidemiol; 2024 Jun; 49():100645. PubMed ID: 38876555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary statistical inference for infectious disease models using Stan.
    Chatzilena A; van Leeuwen E; Ratmann O; Baguelin M; Demiris N
    Epidemics; 2019 Dec; 29():100367. PubMed ID: 31591003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fitting genetic models using Markov Chain Monte Carlo algorithms with BUGS.
    van den Berg SM; Beem L; Boomsma DI
    Twin Res Hum Genet; 2006 Jun; 9(3):334-42. PubMed ID: 16790144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An example of complex modelling in dentistry using Markov chain Monte Carlo (MCMC) simulation.
    Helfenstein U; Menghini G; Steiner M; Murati F
    Community Dent Health; 2002 Sep; 19(3):152-60. PubMed ID: 12269461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A menu-driven software package of Bayesian nonparametric (and parametric) mixed models for regression analysis and density estimation.
    Karabatsos G
    Behav Res Methods; 2017 Feb; 49(1):335-362. PubMed ID: 26956682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian regression in SAS software.
    Sullivan SG; Greenland S
    Int J Epidemiol; 2013 Feb; 42(1):308-17. PubMed ID: 23230299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to particle Markov-chain Monte Carlo for disease dynamics modellers.
    Endo A; van Leeuwen E; Baguelin M
    Epidemics; 2019 Dec; 29():100363. PubMed ID: 31587877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying influential observations in Bayesian models by using Markov chain Monte Carlo.
    Jackson D; White IR; Carpenter J
    Stat Med; 2012 May; 31(11-12):1238-48. PubMed ID: 21905065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian model choice for epidemic models with two levels of mixing.
    Knock ES; O'Neill PD
    Biostatistics; 2014 Jan; 15(1):46-59. PubMed ID: 23887980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the convergence of Markov Chain Monte Carlo methods: an example from evaluation of diagnostic tests in absence of a gold standard.
    Toft N; Innocent GT; Gettinby G; Reid SW
    Prev Vet Med; 2007 May; 79(2-4):244-56. PubMed ID: 17292499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating Contact Network Uncertainty in Individual Level Models of Infectious Disease using Approximate Bayesian Computation.
    Almutiry W; Deardon R
    Int J Biostat; 2019 Dec; 16(1):. PubMed ID: 31812945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Input estimation for drug discovery using optimal control and Markov chain Monte Carlo approaches.
    Trägårdh M; Chappell MJ; Ahnmark A; Lindén D; Evans ND; Gennemark P
    J Pharmacokinet Pharmacodyn; 2016 Apr; 43(2):207-21. PubMed ID: 26932466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics.
    Dodds MG; Vicini P
    Ann Biomed Eng; 2004 Sep; 32(9):1300-13. PubMed ID: 15493516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More stable estimation of the STARTS model: A Bayesian approach using Markov chain Monte Carlo techniques.
    Lüdtke O; Robitzsch A; Wagner J
    Psychol Methods; 2018 Sep; 23(3):570-593. PubMed ID: 29172612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the Bayesian dynamic survival model in medicine.
    He J; McGee DL; Niu X
    Stat Med; 2010 Feb; 29(3):347-60. PubMed ID: 20014356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-exponential tolerance to infection in epidemic systems--modeling, inference, and assessment.
    Streftaris G; Gibson GJ
    Biostatistics; 2012 Sep; 13(4):580-93. PubMed ID: 22522236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian approach to a general regression model for ROC curves.
    Hellmich M; Abrams KR; Jones DR; Lambert PC
    Med Decis Making; 1998; 18(4):436-43. PubMed ID: 10372587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variance components analysis for pedigree-based censored survival data using generalized linear mixed models (GLMMs) and Gibbs sampling in BUGS.
    Scurrah KJ; Palmer LJ; Burton PR
    Genet Epidemiol; 2000 Sep; 19(2):127-48. PubMed ID: 10962474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple introduction to Markov Chain Monte-Carlo sampling.
    van Ravenzwaaij D; Cassey P; Brown SD
    Psychon Bull Rev; 2018 Feb; 25(1):143-154. PubMed ID: 26968853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.